Common marijuana-related cases encountered in the emergency department.

In 2000, Colorado voters decriminalized marijuana for medical use; however, because marijuana use remained illegal under federal law, the number of users was low.[1][1] In 2009, President Obama instructed federal officials not to enforce marijuana laws that were in conflict with state laws, and the

[1]  J. Siple,et al.  Cannabinoid Hyperemesis Syndrome , 2016, The Annals of pharmacotherapy.

[2]  P. Wax,et al.  Acute Poisonings from Synthetic Cannabinoids - 50 U.S. Toxicology Investigators Consortium Registry Sites, 2010-2015. , 2016, MMWR. Morbidity and mortality weekly report.

[3]  Howard S. Kim,et al.  Colorado Cannabis Legalization and Its Effect on Emergency Care. , 2016, Annals of emergency medicine.

[4]  E. Genco,et al.  Marijuana Tourism and Emergency Department Visits in Colorado. , 2016, The New England journal of medicine.

[5]  Hanna K. Flaten,et al.  Butane Hash Oil Burns Associated with Marijuana Liberalization in Colorado , 2015, Journal of Medical Toxicology.

[6]  M. Le Lait,et al.  Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. , 2014, Annals of emergency medicine.

[7]  D. Cao,et al.  An outbreak of exposure to a novel synthetic cannabinoid. , 2014, The New England journal of medicine.

[8]  K. Heard,et al.  Pediatric marijuana exposures in a medical marijuana state. , 2013, JAMA pediatrics.

[9]  K. Heard,et al.  A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. , 2012, Annals of emergency medicine.

[10]  Lex Denysenko,et al.  Cannabinoid hyperemesis syndrome: a case series and review of previous reports. , 2012, Psychosomatics.

[11]  Jason H. Szostek,et al.  Cannabinoid hyperemesis: a case series of 98 patients. , 2011, Mayo Clinic proceedings.

[12]  E. Wallace,et al.  Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm. , 2011, Southern medical journal.

[13]  S. Narang,et al.  A case series of marijuana exposures in pediatric patients less than 5 years of age. , 2011, Child abuse & neglect.

[14]  J. Fisher,et al.  Cannabinoid hyperemesis: a case series. , 2011, The Journal of emergency medicine.

[15]  M. Monahan,et al.  Cannabinoid Hyperemesis and Compulsive Bathing: A Case Series and Paradoxical Pathophysiological Explanation , 2010, The Journal of the American Board of Family Medicine.

[16]  M. Cappell,et al.  The Cannabis Hyperemesis Syndrome Characterized by Persistent Nausea and Vomiting, Abdominal Pain, and Compulsive Bathing Associated with Chronic Marijuana Use: A Report of Eight Cases in the United States , 2010, Digestive Diseases and Sciences.

[17]  S. Passik,et al.  Challenges in Using Opioids to Treat Pain in Persons With Substance Use Disorders , 2008, Addiction science & clinical practice.

[18]  A. Budney,et al.  Marijuana Dependence and Its Treatment , 2007, Addiction science & clinical practice.

[19]  Z. Lin,et al.  Clinical, psychiatric and manometric profile of cyclic vomiting syndrome in adults and response to tricyclic therapy 1 , 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[20]  A. Zinsmeister,et al.  Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled study , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  R. Heddle,et al.  Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse , 2004, Gut.

[22]  K. Mackie,et al.  Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. , 2001, Gastroenterology.

[23]  R. Capasso,et al.  Inhibitory effect of cannabinoid agonists on gastric emptying in the rat , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  P. Hornby,et al.  Delta9-tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors. , 1999, European journal of pharmacology.

[25]  Sridhar,et al.  Delta‐9‐tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double‐blind, randomized study , 1999, Alimentary pharmacology & therapeutics.

[26]  T. Abell,et al.  Idiopathic cyclic nausea and vomiting--a disorder of gastrointestinal motility? , 1988, Mayo Clinic proceedings.

[27]  K. Romanowski,et al.  Butane Hash Oil Burns: A 7-Year Perspective on a Growing Problem , 2017, Journal of burn care & research : official publication of the American Burn Association.

[28]  Franjo Grotenhermen,et al.  Pharmacokinetics and Pharmacodynamics of Cannabinoids , 2003, Clinical pharmacokinetics.

[29]  N. Darmani.  The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. , 2002, The Journal of pharmacology and experimental therapeutics.

[30]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[31]  R L Sperling,et al.  "What a long, strange trip it's been". , 2000, Home healthcare nurse.

[32]  E. Ruiz,et al.  Emergency Medicine: A Comprehensive Study Guide , 1996 .

[33]  N. Vaziri,et al.  Toxicity with intravenous injection of crude marijuana extract. , 1981, Clinical toxicology.